Reuters: Health News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Researchers consider ethics of addressing race in biomedical studies
24 Sep 2018 at 11:05am
(Reuters Health) - Three opinion essays in a major medical journal address the ethics of addressing race in biomedical studies.
Brazil court strips Gilead hepatitis drug patent, politician says
24 Sep 2018 at 10:52am
A Brazilian court has stripped the patent protection of a Gilead Sciences Inc big-selling hepatitis C treatment in Brazil, paving the way for cheaper generics, a presidential candidate who pushed for the move said on Monday.
Malaria mosquitoes wiped out in lab trials of gene drive technique
24 Sep 2018 at 9:40am
Scientists have succeeded in wiping out a population of caged mosquitoes in laboratory experiments using a type of genetic engineering known as a gene drive, which spread a modification blocking female reproduction.
Fewer U.S. adults getting unnecessary knee surgery
24 Sep 2018 at 9:31am
(Reuters Health) - So-called arthroscopic knee surgery is becoming a less common treatment for adults with torn cartilage or painful arthritis as a growing body of evidence shows little benefit from these operations, a U.S. study suggests.
Special Report: Juul copycats flood e-cig market, despite FDA rule
24 Sep 2018 at 8:43am
The sleek Juul electronic cigarettes have become a phenomenon at U.S. high schools, vexing educators and drawing regulatory scrutiny over their sweet flavors and high nicotine content.
Endo puts Vasostrict case against U.S. FDA on hold
24 Sep 2018 at 8:42am
Endo International Plc is halting its lawsuit against the U.S. Food And Drug Administration until the end of the year after the agency made new commitments on the regulation relating to the active ingredient in blood pressure medicine Vasostrict.
EU approves AstraZeneca immunotherapy drug for lung cancer
24 Sep 2018 at 8:37am
AstraZeneca's immunotherapy drug Imfinzi has been approved in Europe for use in lung cancer patients with inoperable disease that had advanced locally but not spread widely around the body, the drugmaker said on Monday.
Electrode treatment, physical therapy combination lets two paralyzed people w...
24 Sep 2018 at 8:12am
(Reuters Health) - Doctors in Kentucky reported Monday that two of four paralyzed patients were able to walk again with limited assistance after treatment with electrical stimulation to the portion of the spinal cord cut off from the brain, combined with intense physical therapy.
Despite Brexit planning, EMA fears disruption for 39 medicines
24 Sep 2018 at 6:56am
Despite actions taken by companies to prepare for Brexit, there is still a risk of serious supply disruptions for 39 medicines as a result of Britain's departure from the European Union, the bloc's drugs regulator said on Monday.
Boston Scientific's drug-coated stent gets FDA approval
24 Sep 2018 at 3:46am
The U.S. Food and Drug Administration on Monday approved Boston Scientific Corp's drug-coated stent Eluvia to treat narrowed arteries in the leg.
AstraZeneca diabetes drug cuts heart risks in major study
24 Sep 2018 at 3:30am
AstraZeneca's diabetes drug Farxiga met a key goal in a major clinical study designed to show its heart-protecting benefits in a wide range of patients, potentially distinguishing it from rivals in a crowded marketplace.
China says new African swine fever outbreak reported in Inner Mongolia
24 Sep 2018 at 2:36am
China said on Monday it has confirmed a new outbreak of African swine fever in the Inner Mongolia Autonomous Region of northern China, as authorities struggle to contain the highly contagious disease.
As China builds biotech sector, cash floods U.S. startups
24 Sep 2018 at 1:17am
For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs to fill the pipeline of his two-week-old drug company.
With new blood test, Roche dives deeper into personal cancer care
23 Sep 2018 at 11:49pm
Swiss drugmaker Roche upped its bet on personalized cancer treatment on Monday, saying it is now ready to sell a blood test around the world that can identify common gene mutations from solid tumors from a patient's blood.
Regulate: ex-world leaders' solution to 'failed' drug war
23 Sep 2018 at 10:04pm
More governments should turn away from a repressive war on drugs that has "failed" and look to proven strategies to implement regulated markets for risky substances, a group of former presidents and leaders said in a report published Monday.